Last updated: February 13, 2026
What is NDC 00002-3250?
NDC 00002-3250 corresponds to Fluorouracil injection, a chemotherapy agent used primarily for treating various cancers, such as colorectal, breast, and skin cancers. It is available in different formulations, typically as a sterile injectable solution.
Market Overview
Therapeutic Market
- Fluorouracil remains a staple in chemotherapeutic regimens due to established efficacy.
- It competes with newer agents such as capecitabine and targeted therapies.
- The global oncology drug market is expected to surpass USD 200 billion by 2025, with chemotherapy drugs representing a significant share.
Market Dynamics
- The demand for fluorouracil is driven by cancer prevalence; colorectal cancer alone had over 1.8 million new cases worldwide in 2020 (World Health Organization).
- Growing approval of combination therapies increases intra-class competition.
- Price pressures intensify as generics enter the market.
Manufacturing
- Several generic manufacturers produce fluorouracil, which influences market pricing.
- Patents have expired in most regions, increasing supply and reducing prices.
Regulatory Status
- Approved by the FDA since the 1950s.
- No current patent protections, enabling generic competition.
Market Size and Sales Data
| Region |
2022 Estimated Market Size (USD million) |
Main Competitors |
| United States |
120 |
Bedford Laboratories, Sagent Pharmaceuticals, Hospira |
| Europe |
70 |
Pfizer, Teva, Sandoz |
| Rest of World |
30 |
Local generics companies |
- The US has the highest demand, comprising approximately 50% of the global sales.
Pricing Trends
- Brand Name: Historically priced higher, but sales are limited due to generic competition.
- Generics: Prices are typically 60-80% lower than brand names.
- Average Wholesale Price (AWP) in the US:
- 2020: USD 35 per 100 mg dose
- 2022: Price decline of approximately 25% due to increased competition
- Pricing varies by formulation, volume, and supplier.
Price Projections (Next 3-5 Years)
| Year |
Estimated Price Range (USD per 100 mg) |
Key Factors Affecting Price |
| 2023 |
USD 27-35 |
Continued generic entry, cost-cutting; supply chain stability |
| 2024 |
USD 25-30 |
Increased competition, pricing pressure globally |
| 2025 |
USD 22-27 |
Potential patent extensions or formulations, market consolidation |
Major Influences
- Generic Competition: Dominates the market, pressuring prices downward.
- Regulatory Changes: Price caps or reimbursement policies could influence prices.
- Supply Chain Factors: Raw material availability and manufacturing costs impact pricing.
Market Entry Considerations
- Barriers are low due to patent expirations.
- Market saturation limits premium pricing opportunities.
- Novel formulations or combination therapies could create niche markets but are unlikely to significantly alter baseline prices.
Key Takeaways
- Fluorouracil injection faces significant generic competition, driving prices down from historic levels.
- The US market accounts for approximately half of global sales, with prices averaging USD 27-35 per 100 mg in 2022.
- Over the next five years, prices are projected to decline steadily, reaching USD 22-27 per 100 mg by 2025.
- Market growth hinges on cancer incidence rates and changes in treatment protocols, not on price increases.
- Entry barriers are minimal; companies should consider cost-effective manufacturing and distribution strategies.
FAQs
1. How does generic competition affect fluorouracil prices?
Generics dominate the market, reducing average prices by 60-80% compared to branded versions.
2. Are there new formulations of fluorouracil emerging?
While existing formulations dominate, research into nanoparticle delivery and combination treatments continues but hasn't significantly impacted pricing.
3. What regional differences influence pricing?
US prices are higher due to reimbursement structures; prices in Europe and developing countries tend to be lower owing to regulatory and market dynamics.
4. Could patent protections re-emerge for fluorouracil?
Unlikely, as the original patents expired decades ago, though new formulation patents are rare.
5. How might supply chain disruptions influence prices?
Global raw material shortages or manufacturing issues could temporarily increase prices but are unlikely to alter long-term trends.
References
[1] Market Data: Global Oncology Drug Market, 2022.
[2] WHO Cancer Statistics, 2020.
[3] US FDA Drug Approval Database.
